Chordia Therapeutics Inc. (TYO:190A)

Chordia Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is September - August.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	May 29, 2025	Aug 31, 2024	Aug 31, 2023
Market Capitalization	15,660	51,534	-
Enterprise Value	12,384	48,276	-
Last Close Price	227.00	780.00	-
PB Ratio	4.82	12.38	-
P/TBV Ratio	4.82	12.39	-
Quick Ratio	15.98	9.19	11.76
Current Ratio	16.72	9.78	11.98
Return on Equity (ROE)	-	-42.19%	-
Return on Assets (ROA)	-	-23.60%	-
Return on Capital (ROIC)	-	-26.00%	-
Return on Capital Employed (ROCE)	-	-	4.70%
Earnings Yield	-12.78%	-3.55%	-
FCF Yield	-12.77%	-3.76%	-
Buyback Yield / Dilution	-	-4.05%	-

Updated Jan 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.